Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer
Industrial Technology
Healthcare
Software
Energy
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
All
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
All
14 Feb 2019
Analysis, Verisec: Security for the future
Equity Research
13 Feb 2019
Analysis Serneke: Construction back into profitability, focus on Karlastaden
Equity Research
13 Feb 2019
Analysis, Coor: Pressure from new contracts
Equity Research
12 Feb 2019
Analysis, Gunnebo: There are positive signs
Equity Research
11 Feb 2019
Analysis, Kancera: Constructive steps
Equity Research
06 Feb 2019
Analysis Lammhults: Solid export growth, somewhat weaker in Sweden
Equity Research
23 Jan 2019
Analysis, NeuroVive: Raising capital for clinical trials
Equity Research
23 Jan 2019
Eq Research Serneke: Nice property deals- focus on Construction profits
Equity Research
16 Jan 2019
Analysis Gunnebo: Better without France
Equity Research
07 Jan 2019
Analysis, Annexin: Reduced visibility
Equity Research
19 Dec 2018
Analysis, Saniona: Obestity treatment punches its weight
Equity Research
14 Dec 2018
Analysis Consilium: Turn-around on its way
Equity Research
14 Dec 2018
Analysis, Biovica: Targets FDA clearance in 2020
Equity Research
14 Dec 2018
Analysis TEO: Can only get better from here...
Equity Research
07 Dec 2018
Analysis FrontOffice: Turnaround case and Fintech in focus
Equity Research
05 Dec 2018
Analysis Bublar: The next big game studio from Sweden?
Equity Research
04 Dec 2018
Analysis, Nuevolution: Early projects showing strength
Equity Research
29 Nov 2018
Analysis, Brighter: In waiting mode
Equity Research
29 Nov 2018
Analysis, Svenska Aerogel: According to plan
Equity Research
27 Nov 2018
Analysis, NeuroVive: Orphan drug portfolio growing up
Equity Research
1
…
47
48
49
50
51
…
64